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View OnlinePharmaceuticals and personal care products in effluent matrices: A survey of
transformation and removal during wastewater treatment and implications for
wastewater management†‡
Rebekah L. Oulton,a Tamar Kohn*b and David M. Cwiertny*a
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DOI: 10.1039/c0em00068jPharmaceuticals and personal care products (PPCPs) represent pollutants of emerging concern,
originating in surface and drinking waters largely from their persistence in wastewater effluent.
Accordingly, a wealth of recent investigations has examined PPCP fate during wastewater treatment,
focusing on their removal during conventional (e.g., activated sludge) and advanced (e.g., ozonation
and membrane filtration) treatment processes. Here, we compile nearly 1500 data points from over 40
published sources pertaining to influent and effluent PPCP concentrations measured at pilot- and full-
scale wastewater treatment facilities to identify the most effective series of technologies for minimizing
effluent PPCP levels. Available data suggest that at best a 1-log10 concentration unit (90%) of PPCP
removal can be achieved at plants employing only primary and secondary treatment, a performance
trend that is maintained over the range of reported PPCP influent concentrations (ca. 0.1–105 ng L1).
Relatively few compounds (15 of 140 PPCPs considered) are consistently removed beyond this
threshold at facilities using solids removal and conventional activated sludge (CAS), and most PPCPs
are removed to a far lesser extent. Further, increases in CAS hydraulic retention time or sludge
retention time do not appreciably increase removal beyond this limit. In contrast, plants employing
advanced treatment methodologies, particularly ozonation and/or membranes, remove the vast
majority of PPCPs beyond 1-log10 concentration unit and oftentimes to levels below analytical
detection limits in effluent. Data also indicate that passive approaches for tertiary treatment (e.g.,
wetlands and lagoons) represent promising options for PPCP removal. We conclude by addressing
future challenges and frontiers in wastewater management posed by PPCPs including analytical needs
for their real-time measurement, energy demands associated with advanced treatment technologies,
and byproducts arising from transformation of PPCPs during treatment.aDepartment of Chemical and Environmental Engineering, University of
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Environmental Impact
This review examines the fate of pharmaceuticals and personal c
occurrence in effluent matrices. We use trends in published data
wastewater treatment facilities to critically evaluate the current a
pollutant class. As outcomes of this review, we identify best-case sce
and configurations, and identify those PPCPs most recalcitrant to t
to focus future ecotoxicological studies on species with the highest p
waters due to effluent discharge. Further, recommendations on alte
loads will help to establish best practices for wastewater managemen
1956 | J. Environ. Monit., 2010, 12, 1956–1978I. Introduction
Over the past decade, overwhelming evidence has shown that
pharmaceuticals and personal care products (PPCPs) are ubiq-
uitous in surface water, groundwater, and even some drinking
waters.1–3 Improved analytical methodologies have lowered
detection limits for these compounds to parts per trillion (ppt)
levels even in the most complex of environmental matrices,
leaving little doubt as to their occurrence in water supplies
around the globe. What remains, however, is a growing list of
questions pertaining to the environmental fate of PPCPs, the
ecotoxicological and human health risks associated with theirare products (PPCPs) during wastewater treatment and their
for influent and effluent PPCP concentrations measured at
bility of wastewater infrastructure to deal with this emerging
narios for PPCP removal over a range of treatment technologies
raditional treatment methodologies. These findings should help
robability of being encountered at appreciable levels in surface
rnative treatments that can be used to minimize effluent PPCP
t in the event standards regulating PPCP removal are adopted.
This journal is ª The Royal Society of Chemistry 2010
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View Onlineoccurrence, and the ability of current water and wastewater
treatment infrastructure to effectively remove these compounds.
The dominant route for PPCP entry into the environment is
through effluent from domestic wastewater treatment. Accord-
ingly, PPCPs and their metabolites are often referred to as
‘‘effluent-derived’’ contaminants,4 originally present in waste-
water from their use in medicinal and personal care products and
ultimately discharged into municipal sewer systems as human
waste products. The tendency for these compounds to persist or
be only partially degraded during treatment or to bypass treat-
ment altogether via sewage overflows will, therefore, contributeRebekah L: Oulton
Rebekah L. Oulton is a graduate
student in the Department of
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Engineering at the University of
California, Riverside. She holds
a Masters Degree in Engi-
neering from Harvey Mudd
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sional Engineer licenses in the
State of California. Prior to
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a Civil and Environmental
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CA, where her project work
included wastewater treatment
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wastewater treatment process modifications for improved removal
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EPA STAR Graduate Fellow.
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This journal is ª The Royal Society of Chemistry 2010to their load in receiving waters, many of which serve as recre-
ational and drinking water sources.
Concerns over the biological activity of PPCPs, specifically
their potential to act as endocrine disruptors,5 have motivated
laboratory, pilot- and full-scale investigations exploring their
occurrence in treatment plant influent, their removal during unit
operations and processes utilized in wastewater treatment, and
the concentrations that persist in treated effluent. Despite over
a decade of study, however, consensus on many of these issues
remains limited. This is due in part to the large number of PPCPs
available commercially and through prescription, the diverse
chemical structure and physicochemical properties common
PPCPs display, and the range of unit operations and operating
conditions employed during wastewater treatment.
This review uses published data pertaining to the occurrence of
PPCPs in wastewater influent and effluent to evaluate treatment
plant performance in removing this emerging contaminant class.
We aim to identify those compounds most likely to persist during
wastewater treatment and, therefore, pose the greatest probability
of exposure after effluent discharge. Removal efficiencies implied
from differences in influent and effluent concentration data are
also rationalized on the basis of results from laboratory, pilot-
scale and full-scale studies examining the fundamental mecha-
nisms of PPCP removal in specific unit operations and processes
employed in wastewater treatment, including traditional (e.g.,
solids removal and biological wastewater treatment), advanced
(e.g., membranes and advanced oxidation processes), and passive
or natural (e.g., lagoons and wetlands) treatment approaches.
Although PPCPs are not routinely monitored in wastewater
treatment, nor is their occurrence in effluent regulated, public
perception and concerns over possible adverse health and
ecosystem effects associated with exposure to PPCPs and PPCP
mixtures have resulted in increased scrutiny of their fate during
wastewater treatment. It can be argued, therefore, that waste-
water engineers should strive to implement treatment approaches
that not only focus on traditional targets such as suspended
solids, biochemical oxygen demand (BOD) and nutrients, butDavid M: Cwiertny
David M. Cwiertny is an Assis-
tant Professor of Chemical and
Environmental Engineering at
the University of California,
Riverside. He holds a PhD in
Environmental Engineering
from Johns Hopkins University,
and a BSc in Environmental
Engineering Science with
a Minor in Chemistry from the
University of California, Berke-
ley. Prior to joining the faculty
at UC Riverside, he conducted
post-doctoral research at the
University of Iowa in a joint
appointment between the
Departments of Civil and Environmental Engineering and Chem-
istry. His research focuses on the fate of pollutants in natural and
engineered aquatic systems and the development of materials-based
strategies for the advanced treatment of water and wastewater.
J. Environ. Monit., 2010, 12, 1956–1978 | 1957
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View Onlinealso efficiently and cost-effectively reduce PPCPs levels in treated
effluent. Accordingly, we draw upon the available literature to
develop recommendations for optimal technologies for lowering
PPCP loads in effluent. Finally, we conclude by identifying
future frontiers and challenges associated with PPCPs in waste-
water, while also addressing the implications and potential
hurdles that PPCPs pose to wastewater management.
We note that we do not address analysis of PPCPs, but refer
the reader to outstanding reviews on this topic,6–13 as well as
recent special issues devoted to PPCPs in Trends in Analytical
Chemistry (June 2007) and Analytical and Bioanalytical
Chemistry (February 2007).
II. PPCP occurrence and removal during wastewater
treatment: An analysis of the current literature
To better predict the occurrence and concentrations of PPCPs in
wastewater effluent, a thorough understanding of their removal
during wastewater treatment is warranted. Wastewater treat-
ment involves a series of physical, chemical and biological unit
operations and processes that are broadly designated as primary,
secondary or tertiary treatment. Primary treatment encompasses
solids removal through the sequential processes of coagulation,
flocculation and sedimentation. Secondary or biological treat-
ment is intended to reduce the organic load or BOD of the
influent via approaches including activated sludge, trickling
filters and membrane bioreactors (MBRs). In this review, the
term tertiary treatment will be applied to all additional steps
beyond primary and secondary operations. These encompass
operations that are physical (e.g., filtration, adsorption),
chemical (e.g., chemical oxidation, disinfection) or biological
(e.g., nutrient removal, wetlands and lagoons) in nature.
A growing number of studies have evaluated PPCP fate at full-
scale wastewater treatment facilities, and their results are
a valuable tool for evaluating PPCP occurrence in wastewater
effluent. Thus, we compiled PPCP influent and effluent concen-
tration data from over 40 published sources, which surveyed the
performance of more than 100 pilot- and full-scale wastewater
treatment facilities or treatment configurations from around the
globe. This effort produced a database (provided in the ESI‡) of
nearly 140 compounds and 1500 data points related to site-
specific PPCP concentrations in the influents of treatment plants
and effluents of specific treatment processes. Analysis was limited
to pharmaceuticals, and, to a lesser degree, some personal care
products. The plants surveyed utilized traditional wastewater
treatment (i.e., solids removal with biological treatment via
activated sludge) as well as more advanced approaches including
MBRs, sand filtration, ultra-, micro-, and nanofiltration, reverse
osmosis, activated carbon, and chemical oxidation via ozonation.
This survey is not meant to be an exhaustive review of all
occurrence studies for PPCPs during wastewater treatment.
Rather, it is intended to serve as a representative database of
typical influent and effluent concentration data that can be used
to assess current performance of wastewater treatment plants
(WWTPs) for PPCP removal. Our analysis is limited to studies
reporting corresponding influent and effluent concentrations for
the same WWTP. Unless noted, studies reporting only influent or
effluent concentrations or studies that only provide inlet and
outlet concentrations for a specific treatment process were not1958 | J. Environ. Monit., 2010, 12, 1956–1978included because they provide no insight as to the total degree of
PPCP removal within the facility (i.e., the difference in concen-
tration between raw influent and final treated effluent).
There are some limitations to this analysis, which draws data
from a broad range of independent sources. First, we only report
compounds quantifiable in both the influent and effluent at the
same WWTP. When values below the effluent detection limit
were reported, the method detect limit (MDL) was used for
comparison to the corresponding influent concentration. These
instances have been noted. Second, we do not differentiate
between various sampling approaches (e.g., grab versus 24 h
composite), nor do we rigorously account for variations in the
operational parameters (e.g., hydraulic residence time, sludge
loading, etc.) at each facility. For studies reporting replicate
concentrations from one sampling event or concentrations from
multiple sampling events temporally close to one another, the
mean concentration was used in our analysis. However, for
studies in which multiple sampling events occurred at a single
facility over an extended time period, data from each sampling
event rather than the mean of all events were used to account for
possible seasonal variations in PPCP loads.A. PPCP removal during conventional (primary and
secondary) wastewater treatment
Studies of PPCP fate during primary wastewater treatment
(i.e., coagulation, flocculation and sedimentation) are generally
limited14–18 because results from drinking water treatment often
suggest that removal during these stages is relatively insignifi-
cant. In contrast, the greatest contribution to PPCP removal
during conventional wastewater treatment occurs during
secondary (i.e., biological) treatment.19 It is, therefore, the most
thoroughly studied process with respect to PPCP removal, and
a multitude of data exist pertaining to treatment efficiency. We
note that for ease of comprehension, the term ‘‘removal’’ will be
used to describe not only processes that result in true removal of
PPCPs from the treatment stream (e.g., adsorption onto sludge
or solids) but also those that lead to PPCP transformation
(e.g., biodegradation or chemical reaction), even though the
latter do not constitute true removal because metabolites and
transformation products will remain in the system.
The most detailed work on PPCP removal during primary
treatment has been conducted by Carbella and co-workers.14,15
They examined the fate of several PPCPs during solids removal
in a WWTP in Spain,14 and in a subsequent work conducted
laboratory experiments to examine the influence of coagulant
identity and loading, temperature, and mixing time on PPCP
removal from WWTP influent.15 As expected, their findings
suggest that PPCP removal at this stage is generally limited, only
occurring to a significant extent (>20%) for very hydrophobic
compounds such as musks (i.e., galaxolide and tonalide),
which exhibit high octanol-water partitioning coefficients
(log Kow  5.5–6.0). Accordingly, it is widely believed that the
predominant PPCP removal mechanism is sorption to suspended
organic matter that is subsequently removed via coagulation,
flocculation and sedimentation. As such, descriptors of PPCP
organic partitioning such as Kow values or solid-water distribu-
tion coefficients (Kd values) are often suggested as predictors ofThis journal is ª The Royal Society of Chemistry 2010
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View OnlinePPCP removal, although insufficient data from primary treat-
ment facilities exist to validate such correlations.
Conventional activated sludge (CAS) is the most common
biological treatment system used in wastewater treatment. PPCP
removal during CAS treatment can be attributed to both
biodegradation and adsorption of the compounds to the sludge.
Adsorption to sludge is particularly important for compounds
with Kdvalues greater than 300 kg L
1.20 For many acidic PPCPs
with low Kd values, removal can be ascribed to biodegradation;
20
this may encompass both metabolic and co-metabolic path-
ways.21 In contrast, fragrances such as galaxolide and tonalide
are predominantly removed via adsorption on sludge.22
Fig. 1 shows the extent of PPCP removal in conventional
wastewater treatment facilities (i.e., those employing primary
treatment and CAS). Data, which pertain to concentrations in
the treatment plant influent and CAS effluents, were obtained
from published sources14,23–55 and are presented on a log-log
scale. This scale is necessary given the broad range of PPCP
concentrations encountered in wastewater treatment, which
spans nearly six orders of magnitude (from 0.1 to 105 ng L1).
Even though some scatter in the data exists, a number of
species are essentially resistant to conventional treatment (data
located along or above the ‘‘no removal’’ line). A useful point of
comparison is effluent levels corresponding to the removal of
1-log10 concentration unit (or 90%) of PPCP. In the U.S.,
national standards for secondary treatment require an average
removal of BOD5 over a 30-day interval of no less than 85%,
56 or
roughly, one-log10 equivalent of removal. Thus, juxtaposition of
the influent-effluent data to this unit-log10 removal line (indi-
cated in Fig. 1) allows WWTP performance toward an emerging
organic pollutant class (i.e., PPCPs) to be compared to the
classical treatment goal for organic removal (i.e., lowering
biochemical oxygen demand).Fig. 1 Comparison plot of PPCP effluent concentration as a function of
influent concentration for WWTPs utilizing traditional treatment oper-
ations (i.e., solids removal and conventional activated sludge). Also
shown in red are lines indicating no PPCP removal and removal corre-
sponding to 1-log10 concentration unit (90% removal). Data with center
dots indicate instances where effluent PPCP concentrations were below
the MDL, in which case effluent data represent the reported MDL.
Additional details regarding data compilation are provided in the text.
This journal is ª The Royal Society of Chemistry 2010As shown in Fig. 1, wastewater treatment plants utilizing only
solids removal and CAS tend to achieve less than a 1-log10
concentration unit of PPCP removal. Of the 818 (ntotal) available
data points pertaining to PPCP concentrations in conventional
treatment plant influents, only 25% (n1-log ¼ 202) exceeded
1-log10 removal in the corresponding effluent concentrations.
Notably, this trend holds over the entire range of PPCP influent
concentrations. It can be generally assumed, therefore, that
facilities not employing some form of tertiary treatment remove
at best 90% of influent PPCPs.
Although ecotoxicological data are lacking to evaluate
whether this removal threshold is sufficient for PPCPs, there are
instances where only 1-log10 removal may be cause for concern.
For example, a PPCP influent concentration of 105 ng L1
(or 100 mg L1) is likely to yield an effluent level of 10 mg L1, and
laboratory studies have shown concentrations on this order can
induce adverse ecotoxicological effects toward aquatic organ-
isms. Specifically, triclosan and ciprofloxacin concentrations as
low as 0.012–1.5 mg L1 were found to induce a strong, concen-
tration-dependent decline in genus diversity of algal communities
sampled upstream and downstream of a WWTP in Kansas.57
As highlighted in a recent review of PPCP biodegradation
during wastewater treatment,58 the available literature does not
allow for generalizations to be made regarding the removal of
different compound classes or even individual compounds.
Indeed, the data presented in Fig. 1 were heavily compound
specific. Fig. 2 presents the log10 removal efficiencies reported for
select compounds in WWTPs employing solids removal and
CAS, illustrating differences in treatment that exist not only
between PPCPs but also among WWTPs.
One of the most highly researched PPCPs is ibuprofen, an
over-the-counter anti-inflammatory. Our database (see the ESI)
contains 65 reports of influent and effluent concentrations from
conventional treatment facilities for ibuprofen, with roughly 70%
(n1-log ¼ 44) reporting treatment efficiencies greater than 1-log10
removal (Fig. 2). Other compounds with particularly high
susceptibility to conventional treatment are shown in Table 1.
These include acetaminophen (or paracetamol), thymol, aspirin,
salicylic acid, estriol, 17b-estradiol, estrone, fenoprofen, bezafi-
brate, bisphenol A, cortisol, cortisone, dexamethasone, and
prednisone. This relatively small subset of compounds, including
ibuprofen, comprise 160 of the 202 (80%) instances in the entire
dataset exceeding 1-log10 removal. Conventional wastewater
treatment may be sufficient for their removal, particularly at low
influent concentrations.
In contrast, certain species are essentially recalcitrant to
conventional treatment. A good example is the antiepileptic
carbamazepine; effluent concentrations from conventional
treatment facilities are practically equal to influent concentra-
tions for all 48 reported instances of carbamazepine detection.
Other compounds that can generally be considered resistant to
primary and secondary treatment are summarized in Table 2.
These include diclofenac, iopromide, metoprolol, and sotalol.
For these compounds, greater than two thirds of available
studies report treatment efficiencies of less than 30% via solids
removal and CAS. We add that there are likely other PPCPs that
fit these criteria, but this subset represents those for which
sufficient amounts of full-scale treatability data (5 or more
published studies) exist.J. Environ. Monit., 2010, 12, 1956–1978 | 1959
Fig. 2 Log10 removal efficiencies for select compounds at WWTPs utilizing traditional wastewater treatment operations (i.e., solids removal and
conventional activated sludge). Each data point corresponds to a published report of influent and effluent concentration for a PPCP at a WWTP using
these treatment technologies. Dashed lines show thresholds indicating no PPCP removal and removal corresponding to 1-log10 concentration unit (90%
removal).
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View OnlineRelative to CAS, PPCP removal by trickling filters has
received less scrutiny, and there are fewer field-scale occurrence
studies at plants using trickling filters. Findings to date generally
agree that trickling filters exhibit lower PPCP removal than CAS
systems.18,47,59 Exceptions are endocrine disruptors, which have
been found to be more effectively removed via trickling filters
than CAS.47 The authors attributed this finding to the ability of
trickling filters to produce immobilized, stable bacterial pop-
ulations that are more capable of degrading recalcitrant
compounds, whereas in CAS systems these bacteria are likely to
get washed out before stable populations can be established.
PPCP removal by secondary treatment systems still faces
several challenges. First, open questions remain regarding the
influence of temperature, as well as of operational parameters
such as hydraulic retention time (HRT) and solids retention time
(SRT) on removal efficiency. As discussed in detail by
Onesios et al.,58 several studies have found an enhanced elimi-
nation of PPCPs during warmer seasons, whereas at least one
study reported no effect of temperature on removal. Opposing
conclusions have also been reached regarding the effect of SRT
and HRT on treatment performance. For example, Maurer
et al.39 reported that the elimination of beta-blockers in WWTPs
depended on HRT. In contrast, Joss et al.20 found no impact of
either SRT or HRT on the removal of seven pharmaceuticals and
fragrances in full-scale WWTPs. Similarly, G€obel et al.60 found
no difference in the removal efficiencies of various antibiotics in
two WWTPs with SRTs of 21–25 and 10–12 days, respectively.
We note that for Figs. 1 and 2, data correspond to CAS systems
with reported HRT values ranging from 1 h to as much as 10
days and SRT values spanning 5 h to over 100 days. Clear trends
in PPCP removal as a function of these variables could not be
discerned in our analysis.
Second, studies of PPCP removal during biological treatment
have mainly focused on the original PPCP, whereas much less
scrutiny has been devoted to the fate of their metabolites. Several
studies60–62 have found that human metabolites are present in
wastewater at higher concentrations than their respective parent1960 | J. Environ. Monit., 2010, 12, 1956–1978compounds. It has also been suggested that some metabolites, in
particular glucuronide conjugates, can be transformed back into
the parent PPCP during secondary treatment.43,62,63 These
examples highlight the need for future studies to include
metabolites when assessing the fate of PPCPs during secondary
treatment.
Finally, as previously noted, it is not yet possible to predict the
propensity of micropollutants to undergo biodegradation based
on their physical-chemical properties (e.g., see the study con-
ducted by Joss et al.).20 This lack of fundamental insight presents
one of the biggest challenges in optimizing PPCP removal during
secondary treatment. In particular, it is difficult to assess the
biodegradation efficiency for new and untested compounds in
the absence of analytical measurements or experimental investi-
gation. Yu et al.33 compared biodegradation efficiencies pre-
dicted using the software package BIOWIN to PPCP removal
measured in full-scale treatment plants and laboratory experi-
ments, finding great discrepancies between predictions and
measurements. Instead of ab initio predictions, we thus currently
rely on empirical data, such as that presented here, to predict
biodegradation efficiency during wastewater treatment. As
a notable example, Joss et al.64 proposed a simple classification
scheme for the biodegradability of pharmaceuticals based on
their biodegradation rate constants obtained in batch experi-
ments. Compounds were divided into three classes according to
their extent of removal, with the authors ultimately concluding
from this scheme that current practices in municipal wastewater
treatment do not remove micropollutants efficiently.B. PPCP removal during advanced wastewater treatment
operations
We now compare the efficiency of PPCP removal in conventional
wastewater treatment to removal efficiencies reported at facilities
employing alternative approaches for secondary treatment
(e.g., MBRs) and tertiary treatment operations for secondary
effluent (e.g., depth and membrane filtration, chemical oxidationThis journal is ª The Royal Society of Chemistry 2010
Table 1 Compounds most susceptible to removal via traditional wastewater treatment (i.e., solids removal and conventional activated sludge) based
upon data available in studies cited herein. Analysis was limited to compounds with at least five reports of corresponding influent and effluent
concentrations.
Compound (CAS #) Chemical Structure Compound Class
Number of Studies
(n) >1-log Removal (% of Studies)
Ibuprofen (15687-27-1) Anti-inflammatory 65 44 (69%)
Thymol (89-83-8) Antimicrobial 18 16 (89%)
Estrone (53-15-7) Hormone 18 8 (44%)
Aspirin (88566-80-7) Analgesic 17 16 (94%)
Fenoprofen (29679-588-1) Anti-inflammatory 17 7 (41%)
Bezafibrate (41859-67-0) Lipid Regulator 15 5 (33%)
Bisphenol A (80-05-7) Endocrine Disrupting
Compound
14 5 (35%)
Salicylic Acid (69-72-7) Anti-inflammatory 13 10 (77%)
17b-Estradiol (50-28-2) Hormone 13 9 (69%)
Estriol (50-27-1) Hormone 8 6 (75%)
Acetaminophen (8055-08-1) Analgesic 7 7 (100%)
Cortisol (8056-11-9) Gluco-corticoid 7 7 (100%)
Cortisone (50-22-6) Gluco-corticoid 7 7 (100%)
This journal is ª The Royal Society of Chemistry 2010 J. Environ. Monit., 2010, 12, 1956–1978 | 1961
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Table 1 (Contd. )
Compound (CAS #) Chemical Structure Compound Class
Number of Studies
(n) >1-log Removal (% of Studies)
Prednisone (53-03-2) Gluco-corticoid 7 7 (100%)
Dexamethasone (50-02-2) Gluco-corticoid 6 6 (100%)
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View Onlinewith ozone, and sorption with activated carbon). When avail-
able, influent-effluent data for each treatment technology are
compared directly to trends observed for conventional waste-
water treatment. For this analysis, reported effluent concentra-
tions from each treatment technology are compared to
concentrations measured in the plant influent; this allows the
extent of PPCP removal achievable via a treatment train incor-
porating each technology to be evaluated. Occasionally, we also
present influent-effluent data comparing the removal efficiencies
of select PPCPs reported for each technology, thereby helping to
identify those approaches most suitable for a particular
compound or compound class.
B.1. Membrane bioreactors (MBRs). To enhance biodegra-
dation of PPCPs, MBRs have emerged as an alternative
approach to CAS. Like CAS, MBRs rely on biodegradation as
the dominant removal mechanism, but their operational
parameters, such as HRT, SRT and sludge concentration differ
greatly. MBRs operate at higher sludge concentrations that yield
increased biological activity compared to CAS. It has therefore
been assumed that they will lead to greater PPCP removal, yet
studies have reported contradictory findings. Enhanced removal
in MBRs has been observed in several studies,38,65–67 albeit not for
all compounds investigated. In contrast, other authors have
reported no benefit of MBRs relative to CAS.20,29,60 A general-
ization for these contrasting findings was offered by Weiss
et al.,68 who concluded that MBRs were only superior for
compounds with an intermediate biodegradation potential,
whereas no benefits were apparent for easily biodegradable or
recalcitrant compounds. The authors therefore questioned
whether the use of MBRs was justified because of its limited
benefits. In contrast, De Wever et al.69 argued that while MBRs
do not necessarily yield higher removal efficiencies, they are
nevertheless beneficial because they exhibit a more consistent
performance and shorter lag times, indicating a superior
response to fluctuating influent concentrations.
Our literature survey suggests that MBRs result in modest
improvements in PPCP removal efficiency relative to CAS
systems. Fig. 3 compares PPCP concentrations measured in
WWTP influents to concentrations measured in the corre-
sponding effluents of MBRs utilized for wastewater1962 | J. Environ. Monit., 2010, 12, 1956–1978treatment.21,27,29,30,38,39,70,71 Also included are data previously
presented in Fig. 1 for conventional wastewater treatment. Using
the threshold of 1-log10 removal to compare treatment efficiency,
49% (63 out of 129 data points) of reported PPCP concentrations
in MBR effluents exhibit this degree of removal, relative to 25%
of PPCP concentrations in CAS effluent.
An alternative means of comparing the performance of PPCP
treatment technologies is through percentiles analysis of reported
treatment efficiencies. This is shown in Fig. 4, where the box plot
illustrates the distribution of reported removal efficiencies,
expressed as the fraction of PPCP remaining in the treated
effluent, for CAS, MBRs and additional technologies to be dis-
cussed subsequently. Maxima and minima in this plot corre-
spond to the 90th and 10th percentile for effluent fractions,
respectively, whereas the boxes span the 25th to the 75th
percentile. The horizontal line within the box indicates the
median value (or 50th percentile). From this analysis, half of all
available data for PPCPs treated by MBR correspond to treat-
ment efficiencies between 41–98% (indicated by the box in
Fig. 4). The range is broader for CAS, with half of all reports for
PPCPs falling between removal efficiencies of 23% and 91%.
Available data therefore support a modest improvement in the
extent of PPCP removal for MBRs relative to CAS.
When comparing PPCP removal by MBR and CAS on
a compound-specific basis, it becomes evident that many of the
same species known to be susceptible to CAS (see Table 1) are
removed to an equal or greater extent by MBRs. However, PPCP
removal can be highly variable between different MBR systems.
One example is carbamazepine, for which most MBRs have little
to no impact on removal,30,65,66,70 although at least one report
indicates far better performance that yielded effluent levels below
detection limits71 (see MBR data in Fig. 5). These differences may
stem from variations in the operating parameters of the MBRs.
Similar to CAS systems, there is little agreement regarding the
effects of SRT and HRT on PPCP removal. Kimura et al.38
reported that an MBR with a SRT of 65 days displayed greater
removal of six acidic PPCPs compared to another MBR with
a SRT of 15 days. In contrast, Joss et al.20 found that neither SRT
nor HRT affected the removal of seven pharmaceuticals in
MBRs. A more nuanced result obtained by other researchers
suggests that the dependence of PPCP removal on SRT differsThis journal is ª The Royal Society of Chemistry 2010
Table 2 Compounds most recalcitrant to removal via traditional wastewater treatment (i.e., solids removal and conventional activated sludge) based
upon data available in studies cited herein. For these compounds, less than 30% removal during treatment was reported in at least two thirds of all
studies. Analysis was limited to compounds with at least five reports of corresponding influent and effluent concentrations.
Compound (CAS #) Chemical Structure Compound Class Number of Studies (n) <30% Removal (% of Studies)
Carbamazepine (298-46-4) Anticonvulsant 48 38 (79%)
Diclofenac (15307-86-5) Analgesic/Anti-inflammatory 35 23 (66%)
Metoprolol (37350-58-6) Beta blocker 9 7 (78%)
Iopromide (73334-07-3) Iodinated Contrast Media 6 5 (83%)
Sotalol (3930-20-9) Beta blocker 6 6 (100%)
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View Onlinebetween compounds. G€obel et al.60 found that the removal of
sulfonamides in a MBR was independent of SRT, whereas the
removal of trimethoprim and several macrolide antibiotics
increased with increasing SRT. They suggest that these differ-
ences in degradation behavior arise from different substrate
dependencies. Sulfonamide degradation appeared to correlate
with the ratio of substrate to sulfonamide concentrations in the
influent. Trimethoprim and macrolide removal, however,
depended on the ratio of substrate to sludge concentration. As
the latter ratio decreases with increasing SRT, the resulting
increase in the biodiversity of the active biomass leads to more
effective transformation of these substances. For a more in-depth
discussion of the influence of HRT and SRT on PPCP removal,
the reader is referred to the work by Joss et al.20
B.2. Sand filtration. The treatment of secondary effluent with
granular media depth filters, which typically use sand as the
filtration medium, is intended to remove suspended solids and
turbidity that persist after clarification. For these constituents,
removal mechanisms are primarily physical in nature
(e.g., straining). PPCP decay also can occur in these systems
through further biological degradation within biofilms on the
filter media.60 Incidental removal of PPCPs associated with the
retained solids is possible, although this contribution is believed
to be small.
A handful of studies report both WWTP influent concentra-
tions of PPCPs and corresponding PPCP concentrations presentThis journal is ª The Royal Society of Chemistry 2010in the tertiary effluent of sand filters.34,40,52,71,72 Similar to
observations with MBRs, available data indicate a slight increase
in the extent of PPCP removal when sand filtration is used for
post-secondary treatment (Fig. 6). Roughly 31% of all data from
sand filters correspond to PPCP removals greater than 1-log10
concentration unit (32 out of 104 data points), only slightly
greater than the value of 25% observed for conventional treat-
ment. From percentile analysis (see Fig. 4), half of all substances
exhibit removal efficiencies greater than 69% when sand filtration
is employed, compared to a median removal of 61% for CAS.
Because PPCP removal by sand filters is largely, if not entirely,
attributable to biological activity, it is difficult to predict from
structural and/or physical properties those PPCPs most suscep-
tible to treatment. Furthermore, there remains little consensus as
to the influence of operational variables such as hydraulic resi-
dence time, hydraulic loading rate, as well as bulk water quality
characteristics, on PPCP removal during filtration. G€obel et al.60
observed considerable differences in the extent of trimethoprim
removal (15% versus 74%) in two sand filters despite comparable
hydraulic retention times and hydraulic loading rates per biofilm
surface area in each case. They attributed this behavior to
differences in the BOD loads to each unit (i.e., higher removal
occurred with lower background BOD levels). Evidence also
suggests that trends in the relative treatability of PPCPs during
sand filtration can likely be inferred from the larger body of
empirical results available for biological treatment. Nakada
et al.40 considered the removal of 24 different PPCPs during sandJ. Environ. Monit., 2010, 12, 1956–1978 | 1963
Fig. 3 Comparison plot of PPCP effluent concentration as a function of
influent concentration for WWTPs utilizing a membrane bioreactor
(MBR) for biological treatment. Also shown in red are lines indicating no
PPCP removal and removal corresponding to 1-log10 concentration unit
(90% removal). For comparison, influent-effluent data obtained with
traditional wastewater treatment (data from Fig. 1) are also shown as
open circles. Data with center dots indicate instances where effluent
PPCP concentrations were below the MDL, in which case effluent data
represent the reported MDL.
Fig. 5 Influent and effluent concentration comparison for carbamaze-
pine during wastewater treatment with various technologies. Data with
a center point indicate those instances where reported effluent concen-
trations were below the MDL, in which case effluent data represent the
reported MDL. Also shown in red are lines indicating no carbamazepine
removal and removal corresponding to 1-log10 concentration unit (90%
removal).
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View Onlinefiltration. Although they rationalized their observations with
sorption tendencies (i.e., correlation to Kow values), the highest
removal efficiencies were obtained for compounds we previously
identified (see Table 1) as highly susceptible to degradation
during CAS (e.g., ibuprofen, estrone, thymol and bisphenol A).
Similarly, G€obel et al.60 noted that the subset of PPCPs elimi-
nated to the greatest extent during sand filtration agreed wellFig. 4 Box plot comparing PPCP removal efficiencies of the different wastew
of removal efficiencies, expressed in terms of fraction of PPCP remaining in
correspond to the 90th and 10th percentile for effluent fractions, whereas b
box represents the 50th percentile (median). Results of percentile analysis
n ¼ 30 instances of corresponding plant influent-process effluent data for dif
1964 | J. Environ. Monit., 2010, 12, 1956–1978with those compounds demonstrating increased elimination
within MBRs.
B.3. Activated carbon. Activated carbon (AC) in either
powdered (PAC) or granular (GAC) form represents the most
widely used sorbent in water treatment, traditionally used for the
removal of taste and odor causing organic compounds inater treatment technologies considered herein. Plots show the distribution
the treated effluent, for each treatment approach. Maxima and minima
oxes span from the 25th to the 75th percentile. The solid line in each
are only shown for treatment approaches for which there were over
ferent PPCPs.
This journal is ª The Royal Society of Chemistry 2010
Fig. 6 Comparison plot of PPCP effluent concentration as a function of
influent concentration for WWTPs utilizing sand filtration for tertiary
treatment of secondary effluent. Also shown in red are lines indicating no
PPCP removal and removal corresponding to 1-log10 concentration unit
(90% removal). For comparison, influent-effluent data obtained with
traditional wastewater treatment (data from Fig. 1) are also shown as
open circles. Data with center dots indicate instances where effluent
PPCP concentrations were below the MDL, in which case effluent data
represent the reported MDL.
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View Onlinedrinking water.73 In this capacity, AC is also a recognized route
for the sequestration of organic micropollutants, and growing
evidence supports its use for removing PPCPs from drinking
water.74,75
Removal of PPCPs by AC occurs via the uptake of
a compound onto the surface (i.e., adsorption) or into the porous
bulk matrix (i.e., absorption) of the sorbent. Characteristics of
AC believed important for performance include surface area,
porosity and pore size distribution, and surface acidity or
basicity, which affects slurry pH and surface charge.75,76 For
PPCPs, compound hydrophobicity, typically quantified in terms
of octanol-water partitioning coefficients (log Kow values), is
often used as a predictor of PPCP removal via AC. Other solute
characteristics including molecular size (e.g., molar volume),
hydrophobic surface area, charge and polarity are also believed
to influence sorption to some extent.75,76
Based largely upon promising results from drinking water
treatment, it is assumed that the use of AC will yield significant
benefits in wastewater effluent quality.71 Unfortunately, there are
few, if any, available data regarding PPCP removal at pilot or
full-scale wastewater treatment facilities incorporating AC. It is
widely accepted, however, that the high levels of effluent organic
matter (EfOM) in wastewater can be expected to limit AC
performance by competing for sorption sites and blocking access
to pores within the sorbent structure.71,74
Because data from WWTPs utilizing AC do not yet exist,
Fig. 7 presents influent and effluent PPCP concentrations from
a full-scale GAC test facility treating drinking water with high
levels of total organic carbon (TOC),71 which provides a reason-
able estimate of AC performance during wastewater treatment.
PPCP removal with GAC at this facility was generally weak.
Only acetaminophen exhibited greater than 1-log10 removal,This journal is ª The Royal Society of Chemistry 2010although hydrocodone, diclofenac and pentoxifylline were
removed to levels below the effluent MDL. Notably, the authors
reported considerably better PPCP removal at another facility
with lower TOC levels and more frequent regeneration and
replacement of the GAC. For wastewater treatment, therefore,
pretreatment to lower TOC and the rate of AC regeneration or
replacement will be key design criteria.71 In particular, fresh AC
outperforms aged material due to the accumulation of TOC and
other non-target species on the aged sorbent.74,77 Such consid-
erations may make PAC a more attractive option for wastewater
treatment; fresh PAC can be added continuously to the process
stream, is not recycled, and its dose can be varied to account for
influent quality.71
Biological activated carbon (BAC) represents a potentially
useful variation on AC treatment. BAC couples PPCP removal
via sorption with biodegradation that occurs within a biofilm on
the sorbent material. The potential benefits of BAC include
biological regeneration of the AC via degradation of sorbed
organic matter over the reactor lifetime, biodegradation of less
biodegradable organics that can be initially sequestered on the
AC and then degraded within the biofilm, and enhanced bio-
logical activity due to the concentrated organic substrate bound
to the AC surface.78 There are multiple instances of BAC
application during wastewater treatment,72,79,80 and it is viewed
by some as a ‘‘core process’’ for wastewater reuse and reclama-
tion.79,80 Fig. 7 includes PPCP data from a full-scale treatment
facility incorporating BAC for tertiary treatment.72 Although the
system displayed good removal for several PPCPs, more work is
needed to understand the design and operational parameters
influencing PPCP removal by BAC.
B.4. PPCP transformation during ozonation. There is rapidly
growing interest in the application of chemical oxidation
processes for the treatment of organic micropollutants in water
and wastewater. This approach utilizes strong oxidants to
chemically transform PPCPs ideally into species lacking biolog-
ical activity that pose no risk to the quality of effluent-receiving
waters. Oxidants typically used for this purpose include ozone
(O3) and hydroxyl radical (cOH), which is utilized in advanced
oxidation processes (AOPs). Because chlorine should not be
viewed as a viable treatment option for PPCPs, no influent-
effluent data or analyses of PPCP removal during chlorination
are presented.
Ozone is used in water treatment as an alternative disinfectant
to free chlorine. Ozone is a selective oxidant with electrophilic
character that targets p-bond systems, non-protonated
secondary and tertiary amines, and reduced sulfur moieties.81,82
Ozone will, therefore, preferentially react at functional groups on
PPCPs with high electron density. In addition to the direct
reactions between PPCPs and ozone, indirect oxidation can also
occur during ozonation due to transient oxidants generated from
ozone decomposition. In water, ozone decays through a series of
radical chain reactions that ultimately yield cOH, one of the most
powerful oxidants in water.81 Unlike ozone, cOH is a non-specific
oxidant capable of degrading a broader range of PPCPs and
other organic micropollutants via radical addition, hydrogen
abstraction or electron transfer mechanisms.56 The non-specific
nature of cOH poses a challenge for wastewater treatment,
however; EfOM and other non-target reductants present at muchJ. Environ. Monit., 2010, 12, 1956–1978 | 1965
Fig. 7 Comparison plot of PPCP effluent concentration as a function of
influent concentration for applications of activated carbon for PPCP
removal. As described in the text, data are shown for the application of
GAC to a high TOC water source (purple circles) and for the use of
biological activated carbon for tertiary wastewater treatment (purple
squares). Also shown in red are lines indicating no PPCP removal and
removal corresponding to 1-log10 concentration unit (90% removal). For
comparison, influent-effluent data obtained with traditional wastewater
treatment (data from Fig. 1) are also shown as open circles. Data with
center dots indicate instances where effluent PPCP concentrations were
below the MDL, in which case effluent data represent the reported MDL.
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View Onlinehigher concentrations than PPCPs can scavenge most, if not all,
cOH generated from ozone.
Encouraged by early results demonstrating PPCP trans-
formation by ozone under conditions representative of water
treatment,75,83–85 attention has focused more recently on the
treatment efficiency of ozone for PPCPs in wastewater.40,46,72,86,87
Huber et al.87 conducted a pilot-scale investigation in which
ozone was applied to secondary effluents from both a CAS
system and a MBR that they spiked with a range of PPCPs. Their
results showed nearly complete degradation of macrolides,
estrogens, and sulfonamides due to transformation of their
tertiary amino groups, phenolic moieties and aniline moieties,
respectively. Diclofenac, naproxen and indomethacin were also
nearly entirely transformed at doses ($2 mg O3/L) that the
authors deemed cost-effective for wastewater treatment.
Although they found very little variability in ozone performance
among the different secondary effluents and total suspended
solids (TSS) loadings tested, certain PPCPs were found to be
relatively resistant to ozonation. Iodinated X-ray contrast media,
which do not react directly with ozone, were only partially
oxidized through reaction with cOH generated from ozone decay.
While the removal of iopamidol, iopromide and iomeprol
increased with increasing ozone dose, only 50–60% removal was
observed at the highest ozone concentrations investigated (5 mg
L1). Diatriozate, an anionic contrast agent, was most resistant
and no statistically significant removal was found at any ozone
dose. It is worth noting that the resistance of iopromide to
ozonation has also been noted in studies focusing on simulated
drinking water treatment,72,75 suggesting that relative trends in1966 | J. Environ. Monit., 2010, 12, 1956–1978PPCP activity toward ozone established for drinking water can
be used to predict their susceptibility during ozonation of
wastewater.
Snyder et al.72 conducted bench-scale investigations of PPCP
ozonation in surface water and wastewater matrices. For
wastewater, their bench-top pilot plant utilized non-disinfected
tertiary (filtered) effluent that contained PPCPs at naturally
occurring levels. They also presented influent and effluent PPCP
concentrations from one full-scale wastewater treatment facility
utilizing ozone as a disinfectant. Generally, their results were in
relatively good agreement with Huber et al.87 In bench scale
studies with tertiary effluent and ozone doses ranging between
2.1 and 8.7 mg L1 (which yielded ozone residuals required for
disinfection), removal of most PPCPs was greater than 90%.
Moreover, bioassays revealed that the estrogenicity of the treated
effluent was reduced relative to that measured before ozonation,
consistent with findings of Huber et al.88 and Dodd et al.,89,90 who
also found that ozonation diminishes the biochemical activity of
many PPCPs. As was also observed in the drinking water studies
of Snyder et al.,72 iopromide, musk ketone, dilantin (phenytoin)
and meprobamate were most recalcitrant to ozonation, each
undergoing only partial (50% or less) removal. The bench-scale
results of Snyder et al.72 also agreed well with their performance
monitoring at the full-scale wastewater treatment facility using
ozonation. Post-secondary treatment at the facility involved
ultrafiltration, pre-oxidation with a small ozone dose, biological
activated carbon (BAC) filtration, and then disinfection and
chemical oxidation with ozone. The use of this process train
resulted in near complete removal for 8 of the 15 micropollutants
considered in the plant’s secondary effluent; for these 8 species,
final concentrations were below the effluent MDL (typically
<0.5 ng L1).
More recent examples of full-scale wastewater ozonation
continue to demonstrate promising results for PPCP removal.
Fig. 8 compares influent and effluent PPCP concentrations at
sites utilizing full-scale wastewater ozonation to concentration
data obtained at facilities only employing conventional treat-
ment practices. The data in Fig. 8 are taken from the afore-
mentioned work of Snyder et al.,72 as well as recent investigations
by Nakada et al.40 and Hollender et al.46 Nakada et al.40 explored
the removal efficiencies of 24 PPCPs via post-secondary treat-
ment with sand filtration and ozonation at a municipal sewage
treatment facility in Tokyo. Hollender et al.46 considered the fate
of 220 micropollutants in a wastewater treatment facility in
Regensdorf, Switzerland that employed activated sludge, fol-
lowed directly by ozonation and then sand filtration. We also
note that plant influent data were not reported in Snyder et al.,72
thus ozonated effluent concentrations are compared to values
measured in secondary effluent prior to any tertiary treatment
processes.
Similar to Snyder et al.,72 full-scale ozonation demonstrations
by Nakada et al.40 and Hollender et al.46 report considerably
enhanced PPCP removal and far lower PPCP effluent concen-
trations than those attainable with primary and secondary
treatment alone. This improved performance is shown in Fig. 8,
with 58% of all data (50 out of 86) corresponding to PPCP
removals of greater than 1-log10 concentration unit. Percentile
analysis (Fig. 4) reveals that half of all effluent data points ach-
ieved removals greater than 94%, while 90% of all dataThis journal is ª The Royal Society of Chemistry 2010
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View Onlinecorrespond to removal efficiencies of 54% or higher. Most
importantly, several compounds traditionally resistant or only
partially transformed during biological treatment are amenable
to treatment via ozonation. These include carbamazepine (see
relevant data in Fig. 5), as well as several compounds within the
classes of beta blockers and anti-inflammatory drugs (Fig. 9).
These results constitute a clear improvement in PPCP removal
over facilities employing only conventional treatment, and
ozonation should be viewed as a valuable treatment tool in the
event toxicological evidence ultimately leads to regulations that
mandate such low PPCP effluent levels.
For wastewater treatment, ongoing and future efforts must
aim to better understand the influence of common aquatic
chemical variables on ozone performance, as well as the relative
importance of O3 and cOH as active oxidants during ozonation.
Immediately after addition, ozone rapidly decomposes due to
reaction with wastewater constituents such as EfOM or oxidiz-
able species including nitrite and reduced forms of sulfur. This
initial decay, referred to as the instantaneous ozone demand
(IOD), can critically influence the efficiency of PPCP removal.
Early work by Buffle et al.91 suggested that this initial ozone
decay coincided with an increase in cOH to levels typically found
in AOPs, which would be beneficial for treatment because of the
potency and non-specificity of cOH. Conflicting results were
reported by Wert et al.,92 however, who found relatively limited
cOH available for contaminant destruction during the initial
stages of ozone decomposition. Thus, it appears that the relative
ozone and cOH exposures may be highly dependent upon the
wastewater matrix. One approach to overcome IOD is to use
higher ozone doses; based upon kinetic modeling, Nothe et al.93
suggest that 5–10 mg L1 of ozone can degrade even the mostFig. 8 Comparison plot of PPCP effluent concentration as a function of
influent concentration for WWTPs utilizing chemical oxidation with
ozone as tertiary treatment of secondary effluent. Also shown in red are
lines indicating no PPCP removal and removal corresponding to 1-log
concentration unit (90% removal). For comparison, influent-effluent data
obtained with traditional wastewater treatment (data from Fig. 1) are
also shown as open circles. Data with center dots indicate instances where
effluent PPCP concentrations were below the MDL, in which case
effluent data represent the reported MDL.
This journal is ª The Royal Society of Chemistry 2010resistant micropollutants regardless of EfOM levels. Such doses
would, however, increase the cost of treatment while also raising
concerns over byproducts generated at such high concentrations.
B.5. PPCP transformation during UV disinfection. During
disinfection with high energy UV light, PPCP degradation can
occur via direct photolysis. For such a scenario, the PPCP must
be a chromophore (i.e., capable of absorbing light energy) and
the energy of light must be sufficient to break chemical bonds in
the PPCP structure. To date, there are no data available on the
transformation of PPCPs in wastewater as a result of UV radi-
ation. Although some work has been conducted in systems
representative of water treatment, less PPCP removal would be
expected in a more complex wastewater matrix, which will
include higher levels of organic matter and other light-scattering
and absorbing constituents.
In one of the most detailed water treatment studies to date,
Canonica et al.94 considered the UV-induced photo-
transformation of 17a-ethinyl estradiol, diclofenac, sulfame-
thoxazole and iopromide. In dilute solutions of buffered water at
pH 7.0, only modest removals (0.4–27%) were observed atFig. 9 Influent and effluent concentration comparison of common (a)
beta blockers and (b) anti-inflammatory compounds during wastewater
treatment with various technologies. Data shape corresponds to different
PPCPs, whereas the color of the data represents the different treatment
technologies utilized. Data with a center point indicate those instances
where reported effluent concentrations were below the MDL, in which
case effluent data represent the reported MDL. Also shown in red are
lines indicating no PPCP removal and removal corresponding to 1-log10
concentration unit (90% removal).
J. Environ. Monit., 2010, 12, 1956–1978 | 1967
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View Onlinea fluence of 400 J m2, a standard value for drinking water
disinfection using UV. Rosenfeldt et al.95 also conducted work
examining the transformation of endocrine disrupting
compounds (bisphenol A, 17a-ethinyl estradiol, and 17b-estra-
diol) upon exposure to UV radiation from either a mono-
chromatic low pressure UV lamp or a polychromatic medium
pressure UV lamp. As in the study by Canonica et al.,94 experi-
ments were conducted in model laboratory systems or with
samples of natural surface waters, and limited removal (<20%)
was observed due to direct phototransformation.
B.6. PPCP transformation during advanced oxidation
processes. Advanced oxidation processes (AOPs) encompass
treatment technologies that rely on the production of cOH or
other radicals, which act as strong oxidants capable of degrading
recalcitrant compounds. Many different AOP technologies for
radical production exist, including heterogeneous photocatalysis
using TiO2 in combination with UV light or solar irradiation,
Fenton’s and photo-Fenton’s reagent, ozone in combination
with peroxide (H2O2) or UV light, UV light in combination with
H2O2, electrolysis, sonolysis, ionizing radiation, ferrate reagent
and others. The majority of research relating to PPCP degra-
dation by AOPs has focused on heterogeneous photocatalysis,
ozone-based AOPs and (photo-)Fenton’s reagent.96 However,
studies investigating other technologies are currently emerging.
Most studies to date have focused on PPCP removal from
laboratory solutions or surface waters, while investigations using
wastewater remain scarce. Of 80 recently reviewed papers
addressing the removal of PPCPs by AOPs,96 only seven used
WWTP effluents as the matrix. Of those studies, four were
conducted in pilot- or full-scale systems, whereas the others were
performed at a laboratory scale. As a result of this scarcity of
wastewater data, we did not include AOPs in our influent-
effluent analyses comparing unit operation performance.
While often viewed as a promising treatment approach, the
advantages of AOPs over conventional chemical oxidation
methods (e.g., ozonation) remain unclear. In a study involving
a wastewater matrix and 36 PPCPs and other micropollutants,
Snyder et al.72 determined that advanced wastewater treatment
by O3/H2O2 only marginally improved PPCP removal relative to
treatment with O3 alone. Similarly, Ternes et al.
86 showed that
AOPs applied to wastewater (O3/H2O2 and UV/H2O2) did not
enhance the removal of iodinated X-ray contrast media, which
are quite recalcitrant to O3. These findings are in contrast to
those obtained for AOP application to distilled or surface waters
matrices,95,97 most likely due to the role of EfOM as a radical
scavenger.
Notably, different AOP technologies can yield different
degradation pathways for the same compounds. In a pilot-scale
study of the removal of diclofenac by photo-Fenton’s reagent
using a compound parabolic collector (CPC) exposed to sunlight,
complete oxidation was attained within 60 min, and complete
mineralization in 100 min.98 Comparison with other oxidative
treatments, namely O3, UV/H2O2 and photolysis, showed that
degradation pathways differed between these AOPs. Similarly,
Radjenovic et al.99 found similar, but not identical pathways for
the degradation of atenolol by heterogeneous photocalatyis and
homogeneous photo-Fenton treatment in the same CPC setup.
Furthermore, the photo-Fenton process was found to be more1968 | J. Environ. Monit., 2010, 12, 1956–1978effective for PPCP removal compared to heterogeneous photo-
catalysis.99,100 Thus, not only PPCP removal efficiencies but also
PPCP transformation pathways will need to be evaluated for
AOPs when considering their application to wastewater. While
AOPs can reduce the estrogenicity2 and antimicrobial activity90
of PPCPs, metabolites may exhibit other toxicity mechanisms.
For example, the toxicity of wastewater effluent, measured by
three bioassays (Daphnia magna, Pseudokirchneriella subcapitata
and Lepidium sativum), was not fully eliminated upon treatment
by heterogeneous photocatalysis using TiO2.
101
B.7. PPCP removal using membrane filtration. Membrane
filtration for the removal of pathogens, micropollutants and salts
has gained importance in drinking water production over the
past decade. More recently, this technology has also attracted
interest as a method to improve PPCP removal from wastewater,
particularly in instances of wastewater reclamation and reuse.
Membrane application to full-scale or even pilot-scale waste-
water treatment systems is still somewhat rare, but there is an
increasing body of literature reporting on this topic.
In contrast to MBRs, where the function of membranes is
predominantly the retention of sludge for biodegradation,
membrane filtration technologies function by rejecting constit-
uents due to pore size restrictions or electrostatic repulsion.
Adsorption onto the membrane also can contribute to
compound rejection, especially for neutral and hydrophobic
substances.102 Membranes are categorized as reverse osmosis
(RO), nanofiltration (NF), ultrafiltration (UF) or microfiltration
(MF) membranes, depending on their molecular weight cut-off
(MWCO). Different membrane types are typically installed in
series, with low-pressure membranes (MF or UF, alone or as
a MBR) providing pre-treatment, followed by one or more units
of tighter, high-pressure membranes (RO or NF) for micro-
pollutant removal. Based on the typical size of PPCPs, only RO
and NF membranes are suited for PPCP removal by purely a size
exclusion mechanism. However, if electrostatic repulsion or
adsorption contributes or is the dominant mechanism,
membranes with pores larger than the compound of interest have
been found to lead to PPCP retention.103 Kimura et al.104
reported that negatively charged disinfection byproducts, PPCPs
and endocrine disrupting compounds in Milli-Q water were
rejected by RO/NF membranes independent of their molecular
size. Conversely, RO membranes have also been found to retain
compounds to a lesser degree than expected based on their
molecular size. This was the case for the hormones estrone and
estradiol,105 as well as for two trihalomethanes106 in actual and
simulated wastewater. This membrane breaching was attributed
to cross-membrane diffusion of the compounds over longer
operation times.
The efficiency of PPCP removal by membrane filtration
depends on a multitude of parameters. Besides MWCO,
membrane material properties such as hydrophobicity, surface
roughness, and charge will affect PPCP removal.107 In addition,
depending on the retention mechanism, different physical-
chemical parameters of the individual substances can influence
their retention. Critical parameters include the molecular weight
and size, acid dissociation constant (pKa), octanol-water parti-
tioning coefficient (Kow), polarity and aqueous diffusion coeffi-
cient.103,107 For example, the retention of antibiotics from theThis journal is ª The Royal Society of Chemistry 2010
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View Onlinewastewater of a veterinary antibiotic production plant by RO/
NF was a function of the molecular weight of the individual
compounds.108 Similarly, the retention of 11 neutral endocrine
disruptors and PPCPs in distilled water by a polyamide RO
membrane was correlated to the molecular weight of the indi-
vidual compounds.109 The retention mechanism in both cases was
therefore attributed to size exclusion. In contrast, the retention of
the same 11 compounds by cellulose acetate membranes
increased with increasing polarity of the compound, indicating
that mechanisms other than size exclusion influenced reten-
tion.109
The composition of the feed water, in particular the organic
matter content, water hardness and pH, also influence retention
efficiency.107 As with chemical oxidation strategies and activated
carbon, the high EfOM content in wastewater represents an
important distinction between membrane treatment for drinking
water and wastewater. The effect of EfOM on PPCP rejection
precludes simple extrapolation from drinking water to waste-
water applications. The effect of membrane fouling by EfOM on
wastewater treatment efficiency therefore warrants further
investigation. Generally, EfOM has been found to exert a reten-
tion-enhancing effect on the removal of charged compounds by
various NF and RO membranes.105,106,110,111 This effect was
attributed either to modification of the membrane surface
charge,106,110,111 to interactions of the EfOM with the
compounds,105,111 or to restriction of the pore size in the case of
loose membranes.110 If adsorption to the membrane is the main
rejection mechanism, however, the presence of EfOM can also be
detrimental. For example, Comerton et al.112 reported that the
rejection of the hydrophobic compound gemfibrozil decreased in
the presence of EfOM, which was attributed to competition for
adsorption sites.
Finally, operational conditions such as the transmembrane
pressure105 and the permeate flux rate102 can affect PPCP reten-
tion. The importance of taking into account actual operational
conditions including flux, recovery and membrane fouling in
laboratory-scale experiments was stressed by Drewes et al.,106
who found that laboratory experiments underestimate contami-
nant removal compared to full-scale systems.
In a recent extensive series of full- and pilot-scale investiga-
tions of wastewater treatment by different membrane types,
makes and configurations, Snyder et al.71 concluded that UF and
MF were only effective for steroid removal, unless used in an
MBR configuration, and that generally, MF outperformed UF.
UF was also found to have limited impact on PPCP removal in
an earlier work by this group.72 Data from these studies per-
taining to influent PPCP levels and their corresponding MF and
UF effluent concentrations are summarized in Figs. 10a and 10b,
respectively. We note that influent data for UF studies corre-
spond to PPCP levels reported in secondary effluent because
levels in the raw influent were not available. These figures clearly
illustrate the slight improvement in effluent quality afforded by
MF and UF relative to conventional treatment practices for
wastewater. Removal of 1-log10 concentration unit is observed
for 64% (16 out of 25) of available plant influent- MF effluent
concentration data, whereas only 9% of UF data (4 out of 44)
correspond to removal greater than 1-log10 concentration unit.
In contrast, Snyder and colleagues70,71 report that wastewater
treatment trains utilizing NF and RO, preceded by appropriateThis journal is ª The Royal Society of Chemistry 2010techniques to improve secondary effluent quality to a level suit-
able for membrane separations, achieve the best removal effi-
ciencies for PPCPs. NF and RO effluent data from Snyder et al.71
and Kim et al.70 are summarized in Fig. 10c and 10d, respectively,
illustrating the exceptional PPCP removal efficiencies exhibited
by NF and RO membranes for the vast majority of compounds.
Roughly 90% of all RO effluent data correspond to PPCP levels
below the method detection limit for analysis, which was typi-
cally on the order of 1–5 ng L1 (data points indicated in Fig. 10d
by a center dot). Comparable results were reported for NF; all
PPCP concentrations in NF effluent correspond to removal
greater than 1-log10 concentration unit (16 out of 16) and all but
one compound (TCEP) were removed to levels below analytical
MDLs.
PPCP removal in RO and NF systems is far superior to that
achieved in treatment trains utilizing other tertiary treatment
operations considered herein. While we had insufficient data for
NF and MF to conduct a comparison of percentiles, analysis of
the available UF data showed that this membrane provides little,
if any benefit, over secondary treatment (see Fig. 4). RO, in
contrast, is characterized by very high PPCP removal efficiencies.
Half of all data correspond to removals greater than 98%,
whereas only about 10% of all RO effluent concentration data
exhibited removal less than 85% (see Fig. 4). Notably, the list of
PPCPs rejected by RO includes carbamazepine (see data in
Fig. 5), which is notoriously difficult to remove by biological
treatment. RO is also among the most effective treatment
approaches for iodinated contrast media (Fig. 11), which as
a class are recalcitrant to biological treatment and only partially
degraded via chemical oxidation methods. A small subset of
compounds, however, have been occasionally detected in RO
permeate, and their breakthrough cannot be rationalized by their
physical-chemical properties. In Snyder et al.,71 membrane
breaching frequently was reported for DEET, meprobamate,
gemfibrozil and sulfamethoxazole, all of which were relatively
poorly removed during the treatment steps preceding RO (MBR,
UF or MF), and were thus present at elevated concentrations in
the RO feed. If a RO double-pass was installed, however, these
remaining micropollutant traces could be fully removed during
the second pass.71
Several aspects of membrane treatment of wastewater have not
conclusively been addressed to date. In a recent overview of the
advantages and drawbacks of NF, van der Bruggen et al.113
identified several parameters that warrant further investigation.
These include membrane fouling, treatment of concentrates, and
the need for modeling and simulation tools. First steps toward
resolving this last aspect, the development of simulation tools,
have been attempted by Kim et al.,70 who constructed a trans-
port/rejection model for neutral and charged compounds based
on membrane properties, which differentiated between convec-
tive and diffusive contaminant transport through the
membranes. As the authors point out, however, their model lacks
predictive capabilities, and thus needs further refinement.
B.8. Passive effluent treatment technologies: Soil aquifer
treatment, wetlands, and treatment lagoons. There is growing
interesting in passive tertiary treatment techniques that utilize
attenuation processes in natural systems as a final polishing step
for wastewater effluent. These include soil aquifer treatment,J. Environ. Monit., 2010, 12, 1956–1978 | 1969
Fig. 10 Comparison plot of PPCP effluent concentration as a function of influent concentration for WWTPs utilizing (a) microfiltration, (b) ultra-
filtration, (c) nanofiltration and (d) reverse osmosis for tertiary treatment. Also shown in red are lines indicating no PPCP removal and removal cor-
responding to 1-log10 concentration unit (90% removal). For comparison, influent-effluent data obtained with traditional wastewater treatment (data
from Fig. 1) are also shown as open circles. Data with center dots indicate instances where effluent PPCP concentrations were below the MDL, in which
case effluent data represent the reported MDL.D
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View Onlinenatural and constructed wetlands, and treatment lagoons. Unlike
most oxidative or separative tertiary treatment options, these
approaches hold the advantage of operating at low energy and
cost, and do not require sludge or brine removal.
During aquifer recharge with treated wastewater effluent, soil
aquifer treatment (SAT) represents a sustainable strategy that
can mitigate potential risks associated with persistent chemicals
including PPCPs.114 SAT takes advantage of natural subsurface
processes that occur primarily in the vadose (unsaturated) zone
to treat reclaimed water that is subsequently stored in the aquifer
and eventually extracted for municipal use115 (i.e., managed
underground storage and recovery operations).116 Most often,
recharge projects utilize rapid infiltration ponds (or surface
spreading basins) built on permeable sediments to introduce
treated effluent into aquifers, a process characterized by fluctu-
ating organic matter concentrations and variable redox poten-
tials arising from the repeated wetting and drying cycles
associated with multiple recharge events.117
The fate of effluent-derived PPCPs during SAT has been
studied either using bench-scale column studies constructed from
aquifer materials or via field-scale monitoring of PPCPs at sites
utilizing treated effluent for recharge.115,118–124 These studies have
generally revealed that a wide variety of PPCPs can be further
degraded during SAT including anti-inflammatories, analgesics,
steroids and some endocrine disruptors,118,119,122,123 with biodeg-
radation representing the most important attenuation
process.118,122,124 Certain compounds, particularly those that are
most resistant to biological degradation, are recalcitrant,1970 | J. Environ. Monit., 2010, 12, 1956–1978however; effluent-derived carbamazepine and primidone were
reported to persist in the subsurface at some reuse facilities for as
long as 6 to 8 years.118,119
PPCP removal in wetlands and lagoons can occur by multiple
mechanisms, including adsorption onto the wetland matrix,
aerobic and anaerobic biodegradation, and photodegradation in
the case of surface flow wetlands and lagoons. Wetlands and
lagoons typically have longer HRTs than conventional treatment
systems. This restricts their use to situations where a large
footprint can be accommodated or where the wastewater volume
is small.
While nutrient removal in wetlands has been extensively
investigated, information regarding the degradation of PPCPs
has only recently started to emerge. In an early study, Gross
et al.125 investigated the fate of selected PPCPs and other
wastewater-derived contaminants during river transport and
subsequent passage through a constructed wetland with a resi-
dence time of 2–4 days. They reported significant removals of
gemfibrozil, ibuprofen and its metabolite hydroxyibuprofen in
the wetland, although this effect was small compared to atten-
uation during river transport.
Matamoros and co-workers126–131 have extensively investi-
gated the fate of PPCPs in constructed wetlands of different
configurations. In a performance comparison of two planted
subsurface horizontal flow wetlands with different water depths,
they found that PPCP removal was better in the shallow wetland.
This finding was attributed to the less anaerobic environment of
the shallow wetland, which therefore had a less negative redoxThis journal is ª The Royal Society of Chemistry 2010
Fig. 11 Influent and effluent concentration comparison of common
iodinated contrast media during wastewater treatment with various
technologies. Data shape corresponds to different PPCPs, whereas the
color of the data represents the different treatment technologies utilized.
Data with a center point indicate those instances where reported effluent
concentrations were below the MDL, in which case effluent data repre-
sent the reported MDL. Also shown in red are lines indicating no PPCP
removal and removal corresponding to 1-log10 concentration unit (90%
removal).
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View Onlinepotential.129,130 Of the PPCPs tested in these two studies, salicylic
acid and carboxy-ibuprofene were removed at >80%, ibuprofen,
hydroxyl-ibuprofen and naproxen at 50–80%, carbamazepine at
<50%, whereas clofibric acid, ketoprofen and diclofenac were
recalcitrant. Degradable PPCPs were removed by biodegrada-
tion, whereas musks were removed by adsorption onto the gravel
bed. In a subsequent study, Matamoros et al.127 compared PPCP
removal in pilot-scale vertical subsurface flow wetlands (VFCW)
to sand filters. They found that both systems operated well at the
design loading rate, but the VFCWs maintained higher removal
rates during overload conditions. Furthermore, the vegetation
present in the VFCWs helped to prevent clogging. Finally,
operation under unsaturated flow conditions achieved better
removals than saturated flow conditions. Most recently, these
authors compared the removal of 13 substances from wastewater
treated by small-scale systems consisting of a sedimentation step
followed by different biological treatment methods. The bio-
logical treatment steps included five horizontal-flow wetlands,
four vertical-flow wetlands, sand filters and biofilters.128 It was
found that removal in all systems was >80%, except for the more
recalcitrant compounds carbamazepine, diclofenac and keto-
profen. However, the vegetated, vertical-flow wetlands consis-
tently performed better than the other systems. This was
attributed to the unsaturated flow and presence of vegetation,
which results in better oxygenation compared to the horizontal
wetlands. As a summary of their work, the authors advocate
planted VFCWs as an appropriate treatment option because they
require lower HRTs and achieve better removal than horizontal
flow configurations.
Similar to wetlands, PPCP removal in treatment lagoons or
ponds has not received much attention to date. From one of theThis journal is ª The Royal Society of Chemistry 2010few studies published on this topic, it appears that lagoons
perform as well as CAS treatment systems for the degradation of
biodegradable compounds.32 For more recalcitrant compounds,
however, lagoons have been found to outperform CAS systems.
This was the case for gemfibrozil and diclofenac removal in three
Canadian lagoons treating municipal wastewater,32 as well as for
carbamazepine removal in French treatment plants consisting of
trickling filters followed by ponds, or of a sequence of ponds
alone.61 In the latter case, the enhanced removal of carbamaze-
pine compared to CAS systems was attributed to adsorption
onto organic matter as well as photodegradation in the matu-
ration ponds.
The efficiency of PPCP removal in a combined lagoon/wetland
treatment system was investigated by Conkle et al.,132 who studied
the fate of PPCPs in wastewater that first entered a series of
aeration lagoons, followed by a constructed wetland, UV disin-
fection, and finally a natural wetland. Of the nine PPCPs followed
throughout this treatment, most were removed to greater than
1-log10 concentration unit. The two most recalcitrant compounds,
carbamazepine and sotalol, were removed to a lesser extent
(52 and 81%, respectively). Overall, the authors concluded that
this natural treatment setup performed better than conventional
wastewater treatments with respect to PPCP removal, which they
attributed to the longer residence time of the system (30 days).
Similar conclusions were presented by Hijosa-Valsero et al.,126
who monitored the removal of selected PPCPs from primary
treated municipal wastewater in three full-scale hybrid systems
consisting of different arrangements of ponds, surface and
subsurface wetlands in series. The observed removal efficiencies
were compared to those obtained in a conventional WWTP, and
removal in the passive systems was generally greater. Interest-
ingly, the recalcitrant compound diclofenac, which was not
removed in the WWTP, was degraded by 65–87% in the passive
systems. The improved removal efficiency was attributed to the
coexistence of different microenvironments in the passive system,
which leads to a variety of parallel pathways for PPCP degrada-
tion. In WWTPs, in contrast, the physicochemical conditions tend
to be more homogenous, limiting the number of degradation
pathways that exist.
A compilation of influent and effluent data from studies doc-
umenting PPCP removal in lagoon and wetland treatment
systems18,126,128,131–133 confirms that such passive or natural
treatment approaches perform favorably relative to conventional
wastewater treatment systems (Fig. 12). Using the removal of
1-log10 concentration unit as a basis for performance compar-
ison, 48% of available data (38 out of 79) achieve this threshold
at facilities utilizing lagoons and/or wetlands (natural or con-
structed). Furthermore, percentile analysis indicates that these
treatment methods yield PPCP removal on par to ozonation
(see Fig. 4). In fact, 90% of effluent concentration data from
facilities using lagoons and/or wetlands correspond to removal of
at least 43%, which is an improvement over CAS or MBRs for
biological treatment. While promising, additional research and
full-scale performance data are needed to further validate the
early performance reports for these natural or passive treatment
methods. Also, the advantages conferred by these approaches
(e.g., lower energy requirement and operating costs) must be
weighed against the requirement of a considerably larger spatial
footprint.J. Environ. Monit., 2010, 12, 1956–1978 | 1971
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View OnlineIII. Predicting and minimizing PPCP occurrence in
wastewater effluents
A. Recommendations for optimizing PPCP removal
In choosing between possible biological treatment options
(e.g., CAS, MBR, etc.) to optimize PPCP removal, it is generally
observed in Figs. 1 and 2 that removal by CAS only exceeds
1-log10 concentration unit (or 90%) for a relatively small subset
of PPCPs (Table 1). Interestingly, existing influent and effluent
data indicate that for conventional biological treatment, PPCP
removal appears relatively invariant with respect to microbial
community composition, as well as the HRT and SRT conditions
applied. We therefore conclude that the maximum removal
potential by conventional biological treatment likely cannot be
expanded much beyond current performance through simple
manipulation of process operating conditions. Rather, it appears
that improvements can only be achieved by upgrading to a more
advanced biological treatment technology such as MBRs,
although increases in PPCP removal may only be marginal at
best (see Fig. 4). Alternatively, tertiary treatment approaches in
parallel that couple biodegradation with other attenuation
processes appear promising. These include biological activated
carbon (BAC), which couples biodegradation and sorption, or
natural/constructed wetlands, in which a multitude of PPCP
removal mechanisms can occur simultaneously with biodegra-
dation.
Of course, PPCP removal also can be augmented using tertiary
treatment approaches that do not rely on biodegradation. The
level of PPCP removal afforded by membrane technologies may
be most appropriate when high quality effluent is desiredFig. 12 Comparison plot of PPCP effluent concentration as a function
of influent concentration for WWTPs utilizing wetland or lagoon treat-
ment systems. Also shown in red are lines indicating no PPCP removal
and removal corresponding to 1-log10 concentration unit (90% removal).
For comparison, influent-effluent data obtained with traditional waste-
water treatment (data from Fig. 1) are also shown as open circles. Data
with center dots indicate instances where effluent PPCP concentrations
were below the MDL, in which case effluent data represent the reported
MDL.
1972 | J. Environ. Monit., 2010, 12, 1956–1978(e.g., indirect or direct potable reuse). Ozonation may be more
broadly applicable for WWTPs simply aiming to lower effluent
PPCP loads because it can be directly applied to secondary
effluent46 without the extensive pretreatment required for NF or
RO. Evidence also suggests that other chemical oxidation
approaches including AOPs hold limited, if any, real advantage
over ozonation.72
Notably, there may be additional benefits for the sequential
application of ozone and BAC to secondary effluent. During
their full-scale evaluation of wastewater ozonation, Hollender
et al.46 recommended the use of a biological sand filter post-
ozonation to remove byproducts of oxidation including nitro-
sosdimethylamine (NDMA) and biologically assimilable carbon
such as aldehydes. Treatment of ozonation effluent with BAC
should provide comparable, if not greater, benefit due to the
nature of the activated carbon sorbent used as the filter media.
We caution, however, that these recommendations are based
entirely on lowering PPCP effluent concentrations and do not
fully consider the economic impact of increased reliance on
advanced treatment technologies, which is discussed in greater
detail subsequently.B. Predicting PPCP removal efficiency and occurrence in
treated effluent
Predictive models that estimate PPCP persistence as a function of
the compound’s physical and chemical properties have been
developed with varying degrees of success for specific water
treatment technologies.43,70,75,76,134 Unfortunately, to date no
single approach has emerged that accurately predicts PPCP
removal during wastewater treatment over a wide range of
treatment technologies, water quality conditions, and PPCP
compounds and compound classes.
Predictions of PPCP persistence in effluent will likely have to
be based on experimentally gathered evidence rather than simple
physical and chemical principles governing their fate during
treatment. For example, several substances are almost univer-
sally shown to persist during conventional wastewater treatment.
From our literature survey, PPCPs for which a removal of less
than 30% has been consistently reported include carbamazepine
(ntotal ¼ 48; 79% of which report <30% removal), diclofenac (35;
66%), metoprolol (9; 78%), sotalol (6, 100%), and iopromide (6;
83%) (Table 2). Our analysis is corroborated by others; carba-
mazepine and diclofenac have been found in >90% and >80%,
respectively, of surveyed river water samples in Europe.135
Glassmeyer et al.136 detected carbamazepine in >80% of samples
in and around 10 WWTPs across the United States. Miege
et al.,137 who conducted a similar review of PPCP occurrence in
WWTPs, reported the presence of carbamazepine in all of 63
effluents considered, while diclofenac and metoprolol were also
found with high regularity (85% and 97% of effluents evaluated,
respectively). It can thus be concluded that these compounds are
among the PPCPs most resistant to biodegradation. Moreover,
any of these species could serve as a good indicator of wastewater
inputs to surface water; they are consistently present in influent
at concentrations well above MDLs, are recalcitrant to removal
during conventional treatment, and municipal wastewater
effluent constitutes an important entry route into surface water.This journal is ª The Royal Society of Chemistry 2010
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View OnlineSeveral methods have also been proposed utilizing the occur-
rence of select PPCPs with well-characterized behavior in
WWTPs, referred to as indicator or marker compounds, to
evaluate treatment system performance. As indicators of
biodegradation-based treatment, two approaches have been
proposed. Several authors suggest the use of enantiomeric ratios
of substances such as naproxen128 or propranolol138 to determine
the extent that a wastewater has undergone biological treatment.
This method is based on the insight that microorganisms pref-
erentially degrade one enantiomer in a racemic mixture, whereas
dilution would affect both enantiomers equally. Other
studies136,139 suggest monitoring the ratio of biodegradable
PPCPs to recalcitrant species in wastewater effluent, a ratio that
should decrease with increasing treatment efficiency. Based on
the data compiled for this review, suitable choices for biode-
gradable compounds include acetaminophen, ibuprofen, thymol,
aspirin or salicylic acid (Table 1). Hormones such as estrone and
estradiol could also be used, but their effluent concentrations are
frequently below method detection limits. Among the most
frequently detected biologically recalcitrant compounds, we
propose the use of carbamazepine, diclofenac, metoprolol, or
sotalol (Table 2), as well as the class of iodinated X-ray contrast
media (Fig. 11).
WWTPs employing tertiary treatment may require a different
set of indicators compounds. For example, biologically recal-
citrant carbamazepine and diclofenac are readily degraded
during ozonation, whereas several X-ray contrast media are
not.46 Using three sets of indicator compounds corresponding
to (i) biodegradable PPCPs, (ii) biologically recalcitrant but
oxidatively degradable PPCPs (e.g., carbamazepine and diclo-
fenac), and (iii) PPCPs recalcitrant to both biodegradation and
chemical oxidation (e.g., iopromide or other iodinated contrast
media) could provide information regarding not only the
overall treatment system efficiency, but also the treatment stage
where failure occurs. For example, Dickenson et al.140 recom-
mended dilantin (phenytoin), DEET, meprobamate, and
iopromide as indicators to assess the conditions during ozon-
ation of tertiary treated wastewater for indirect potable reuse
processes. These species represent those most resistant to both
biodegradation and direct reaction with ozone. Thus, detection
of these PPCPs in the absence of others known to be readily
degradable by ozone (e.g., carbamazepine and diclofenac)
would indicate an ozone system operating as expected. Alter-
natively, the absence of these indicator species after ozonation
would indicate high exposure levels to cOH capable of
degrading nearly all PPCPs. Identification of carbamazepine or
diclofenac after ozonation would suggest inefficient oxidizing
conditions.
We note that an alternative approach utilizing bulk water
parameters as indicators for ozonation performance was
explored by Wert et al.141 They suggested a simple method for
monitoring PPCP removal that relies upon changes in UV254
absorbance and color of the wastewater upon ozonation.
Oxidation of ozone-reactive compounds was found to correlate
well with a reduction in UV254 absorbance between 0–50%, and
PPCPs that react predominantly with hydroxyl radicals corre-
lated well with a UV254 reduction of 15–65%. Similarly, the loss
of true color also could be correlated with the extent of PPCP
degradation during ozonation.This journal is ª The Royal Society of Chemistry 2010IV. Current and future challenges posed by PPCPs
for wastewater management
Despite recent progress toward better understanding of PPCP
removal during water treatment, many challenges associated
with PPCPs in wastewater remain. Here, we introduce a selection
of issues that will be critical for the development of reliable
technologies for PPCP removal and sustainable practices for
wastewater management. These include emerging methodologies
for PPCP analysis and monitoring; byproducts generated from
the transformation for PPCPs during wastewater treatment; and
potential challenges associated with an increased reliance on the
advanced treatment technologies that have proven thus far to be
best suited for PPCP removal. We do not address the pressing
need for ecotoxicological data that convincingly demonstrates
the adverse impacts associated with exposure to PPCPs or PPCP
mixtures at levels anticipated in wastewater effluent, which is
beyond the scope of this review. For a detailed treatment of this
topic, the reader is referred to a review of pharmaceutical eco-
toxicology by Fent et al.142A. Analytical approaches for identification of unknowns and
real-time PPCP monitoring
Current frontiers in PPCP analysis are geared toward the iden-
tification and quantification of yet unidentified species, as well as
transformation products generated during treatment. The iden-
tification of such unknown substances involves the application of
high-resolution mass spectrometry (MS) methods, such as
(quadrupole) time-of-flight-MS/MS and linear ion trap MS.
These techniques allow the identification of non-target
compounds in the absence of analytical standards. Applications
of high-resolution mass spectrometry techniques to identify non-
target compounds have recently been demonstrated.143,144
Another growing area in PPCP analysis is the development of
real-time detection and quantification tools, which allow the
continuous monitoring of PPCPs in effluents. Vanderford
et al.145 presented a mass spectrometry-based method capable of
real-time monitoring of triclosan and its degradation products
during chlorination. In this approach, samples were directly
injected into a mass spectrometer, thereby avoiding the need for
chromatographic separation, sample quenching or derivatiza-
tion. While this technique has to date only been applied to
controlled lab experiments, its expansion to applications
involving real effluents could be envisioned.
For real-time monitoring, sensor-enabled technologies may
prove more suitable than MS-based techniques. Sensors rely on
species detection via a recognition element, such as antibodies,
enzymes or membrane-imprinted polymers. An overview of the
current (bio)sensor-based applications for the detection of organic
contaminants in environmental samples is presented by Rodri-
guez-Mozaz et al.146,147 Compared to mass spectrometry applica-
tions, sensor-based technologies hold many favorable attributes.
Potentially they can consume less sample volume, do not require
trained personnel for operation, are less sensitive to matrix effects
and are more cost-effective. Multi-analyte detection, however,
remains challenging,147 and more studies evaluating the sensitivity,
selectivity and robustness of (bio)sensor-based technologies in
complex environmental matrices are required.J. Environ. Monit., 2010, 12, 1956–1978 | 1973
D
ow
nl
oa
de
d 
on
 1
8 
Fe
br
ua
ry
 2
01
1
Pu
bl
ish
ed
 o
n 
12
 O
ct
ob
er
 2
01
0 
on
 h
ttp
://
pu
bs
.rs
c.
or
g 
| do
i:1
0.1
039
/C0
EM
000
68J
View OnlineB. Next generation treatment byproducts
PPCPs undergo, to varying extents, chemical and/or biologically
mediated transformations during wastewater treatment. As
previously mentioned, however, degradation should not be
equated with removal. All chemical and biological reactions
result in the formation of products, many of which may share
structural similarities with or retain the biochemical activity of
the parent PPCPs from which they are derived.
To date, most concern has focused on the potential formation
of hazardous transformation products during chlorination of
PPCPs. Laboratory investigations with model systems have
convincingly demonstrated that chlorination of common PPCPs
can lead to the formation of known toxicants and probable
carcinogens. Rule et al.148 demonstrated that free chlorine doses
typically used in water treatment could react with the common
antimicrobial triclosan to produce chloroform. Likewise, Bedner
and MacCrehan149 found that chlorination of acetaminophen
under conditions simulating wastewater disinfection led to the
production of several products, including the known toxicants
1,4-benzoquinone and N-acetyl-p-benzoquinone imine, which
are associated with lethal acetaminophen overdoses.
Of additional concern are transformation products uniquely
formed during PPCP chlorination.150,151 At low doses or short
contact times, reaction with chlorine is likely to only produce
small modifications in the parent compound structure. Dodd and
Huang152 found that trimethoprim reacts readily with free chlo-
rine yielding products that were predominantly multi-chlori-
nated and hydroxylated. Early work examining the chlorination
of 17b-estradiol153,154 observed similar phenomena; seven trans-
formation products were identified including 2,4-dichloro-17b-
estradiol, monochloroestrone, and 2,4-dichloroestrone.
These unique species generated during chlorination represent
the next generation of disinfection byproducts. They are viewed
by many as a cause of concern with respect to their biological
activity and possible toxicity, particularly mono- and di-chlori-
nated products that largely retain the structure of the parent
PPCP. To date, several studies have employed in vitro cell assays
to evaluate changes in biochemical activity induced by chlori-
nation. The most widely applied of these approaches is the YES
(Yeast Estrogen System) assay, which screens for estrogenicity.
Several studies have used the YES assay or similar to conclude
that chlorination of estrogenic hormones and endocrine dis-
rupting compounds yields end products of lesser or no estro-
genicity.155,156 As analytical methods for detecting, identifying
and isolating these transformation products become more
readily available, future research must continue to explore how
physicochemical characteristics and biological activity of
partially chlorinated transformation products differ from the
behavior of the parent PPCP. Furthermore, additional toxico-
logical studies with transformation products are warranted, so as
not to place too strong an emphasis on the results of in vitro
toxicity assays; PPCPs may result in toxic endpoints other than
estrogenic response that may only be observed through investi-
gation of whole organism (i.e., in vivo) toxicity.
Even for chemical oxidation strategies such as ozonation,
which effectively degrades most PPCPs, mineralization (i.e., the
complete conversion into inorganic components such as CO2) is
not likely a realistic goal. Therefore, further identification and1974 | J. Environ. Monit., 2010, 12, 1956–1978characterization of byproducts generated during wastewater
treatment are needed. Early work in this area conducted by
Huber et al.88 examined the ozonation of 17a-ethinyl estradiol.
Although small amounts of estrone and 17b-estradiol were
observed, they concluded that most products exhibited chemical
structures considerably altered from the parent, consistent with
the loss in estrogenic activity measured in assays of the ozonation
products.
More recent analysis of ozonation products seems to support
a larger role of cOH than may have originally been anticipated
for PPCP treatment with ozone. Benner and Ternes157 identified
the products of metoprolol ozonation, primarily observing
transformation products rich in aldehyde moieties and others
indicative of hydroxylation reactions. Although they worked in
model systems consisting of raw wastewater and secondary
wastewater effluent spiked with metoprolol, these trans-
formation products seem to suggest a significant role for cOH
during ozonation of PPCPs in wastewater matrices. Similarly,
laboratory studies conducted by Radjenovic et al.99 on the
ozonation of antibiotics in both distilled water and secondary
wastewater effluent revealed transformation products most
consistent with cOH reaction pathways, despite the relatively
high affinity that many of the parent antibiotics exhibit toward
ozone. Notably, two products of roxithromycin exhibited high
refractoriness to ozonation. Both products maintained an intact
tertiary amine moiety suggesting that antimicrobial activity may
have been preserved after ozonation.
As pointed out by Snyder,2 future research should not focus
solely on the ecotoxicity of oxidation metabolites. Byproducts of
ozonation include bromate (BrO3
) in bromide-containing
waters, and organic products generated from the ozonation of
DOM, which is present in wastewater at much higher concen-
trations than micropollutants. In a recent comparison of ozone
to ozone-based AOPs, Wert et al.158 found that ozone yielded
a smaller amount of these byproducts relative to AOPs, which
may be due to a lower degree of cOH exposure during ozonation.
Nevertheless, further research regarding the formation, ecotox-
icological impacts and approaches for mitigating byproducts of
wastewater ozonation and similar chemical oxidation strategies
is warranted before such treatment measures can be routinely
implemented.C. Challenges of increased reliance on advanced treatment
technologies
Oft-cited detriments of advanced wastewater treatment,
including chemical oxidation and membrane technologies, are
their high energy requirements and the associated ecological and
economical costs. If advanced treatment of wastewater is deemed
necessary, a careful evaluation of these costs should be per-
formed when identifying an optimal treatment method. For
example, energy consumption was recently evaluated at a full-
scale plant using ozonation to degrade micropollutants in
wastewater.46 Results indicated that micropollutant concentra-
tions could be drastically reduced with an energy demand from
ozonation that amounted to only 12% of the total energy cost of
a typical nutrient removal plant. This energy cost increased by
approximately 30% if the production of pure oxygen for ozone
generation was taken into account.This journal is ª The Royal Society of Chemistry 2010
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View OnlineIn a comparison of energy consumption associated with
different advanced treatment methods, Rosenfeldt et al.159
compared the energy use for different H2O2-based AOPs and
ozone applied to surface and ground water. They found that at
a low cOH yield, ozone was the most efficient technology,
whereas at higher yields the difference became negligible. Future
direct comparisons of chemical oxidation-based treatment tech-
nologies should also include AOPs that can be operated with
sunlight as the energy source and/or without the addition of
H2O2, the use of which contributes greatly to operation costs.
Two examples of AOPs that can use sunlight as the main energy
source are homogeneous photo-Fenton processes using ferrous
iron and H2O2, and heterogeneous solar photocatalysis with
titanium dioxide. A life cycle analysis of these two AOPs coupled
to biological treatment was evaluated in a noteworthy study by
Munoz et al.,160 taking into account the impact categories of
global warming, ozone depletion, human toxicity, freshwater
aquatic toxicity, photochemical ozone formation, acidification,
eutrophication, energy consumption, and land use. Results
showed that solar photo-Fenton has a lower environmental
impact than solar heterogeneous photocatalysis for the treatment
of industrial wastewater. The solar photo-Fenton process thus
seems to be a more reasonable option if AOPs are to be
employed.
In addition to those advanced methods already demonstrated
as effective for PPCP removal, emerging oxidants, such as ferrate
(Fe(VI)) and permanganate (Mn(VII)), could be scrutinized for
their efficiency and environmental impact. Because these
oxidants are not as commonly used as chlorine and ozone, PPCP
removal by permanganate and ferrate has received less attention
to date. However, it has been shown that they are capable of
efficiently degrading endocrine disruptors and antimicro-
bials,161,162 as well as carbamazepine.163 Furthermore, their
disinfection byproducts are considered benign164 and the prod-
ucts of their reduction (i.e., MnO2 (s) and Fe(OH)3(s)) can be
exploited as coagulants to further contribute to the removal of
PPCPs and EfOM (see Hu et al.163 and references therein).
Similar considerations should also be applied for membrane
technologies. Snyder et al.71 emphasized that while membranes
show great potential for enhancing wastewater quality, the
benefits of membrane treatment must be weighed against
possible detriments. Besides high energy requirements, these also
include the removal and disposal of the concentrated brine
produced during the process. Indeed, an economic analysis
conducted by Jones et al.165 suggests that the use of membrane
filtration technologies for wastewater treatment may be ulti-
mately both economically and ecologically undesirable as a result
of the high energy demand.V. Conclusions
Based upon available data, technological solutions currently
exist that can be used to lower PPCP levels in wastewater effluent
to sub-ng L1 levels that push the limits of current analytical
instrumentation. Experimental evidence clearly demonstrates
that current limitations in conventional treatment practices can
be overcome with advanced treatment strategies including
chemical oxidation with ozone or the use of membrane tech-
nologies such as RO and NF, all of which improve considerablyThis journal is ª The Royal Society of Chemistry 2010effluent quality when incorporated into wastewater treatment
trains. We caution, however, that zero is neither a reasonable nor
achievable treatment goal for PPCPs. Recent advances in engi-
neered wastewater treatment must now be matched by ecotox-
icological data that establish acceptable levels of PPCPs in
wastewater effluent and regulations regarding thresholds for
PPCP removal. Until these criteria are established, appropriate
treatment technologies will be difficult to identify with certainty.
Ultimately, adequate removal of PPCPs from wastewater may
require rethinking current paradigms in wastewater treatment
and its associated infrastructure. For example, available data
suggest that the use of passive treatment options often affords
better PPCP removal than conventional treatment systems, while
also providing the benefits of low energy input and minimal
operation and maintenance costs. In populated areas, however,
implementation of such systems may be limited by their large
space requirement. Therefore, a model for future wastewater
treatment infrastructure may involve decentralized systems that
serve smaller population segments. Such systems could include
primary or secondary treatment, followed by passive tertiary
treatment with SAT, constructed wetlands or lagoons.
There is an increased reliance on reclaimed wastewater for
applications including irrigation, habitat restoration, and
potable reuse in water-stressed regions. Therefore, methods must
be developed that better quantify the economical and ecological
benefits of advanced treatment practices that enable such
wastewater reuse strategies. Munoz et al.166 used life cycle anal-
ysis to compare the toxicity implications of different water reuse
strategies. They considered direct reuse of secondary effluent, as
well as reuse of three tertiary treated effluents (RO, ozonation
and H2O2/O3). Their findings highlight the importance of non-
regulated pollutants, including PPCPs, in the toxicity assessment
of reclaimed water. Specifically, tertiary effluents exhibited lower
ecotoxicity than secondary effluent, indicating tangible ecolog-
ical benefits associated with advanced treatment. In the future,
these benefits must be better quantified and weighed against
more easily identifiable detriments commonly linked to advanced
technologies, such as the energy demand associated with
membrane technologies.
In all the scenarios outlined above, it is important to empha-
size the need for more research involving actual wastewater
matrices and full-scale WWTPs. This is particularly true for
advanced treatment technologies such as membranes, ozonation,
AOPs and activated carbon, for which current data are relatively
limited. Because the efficiency of these strategies will be highly
variable in response to the organic matter loads in wastewater,
the current divide between water and wastewater PPCP research
must be closed.
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